ClearPoint Neuro, Inc. CLPT 深 沪
已收盘 02-06 16:00:00 美东时间
13.46
+0.890
+7.08%
华盛通- 最 高13.6044
- 今 开12.70
- 成交量 42.27万股
- 最 低 12.70
- 昨 收 12.57
- 总市值 4.00亿
- 52周最高 30.0999
- 市盈率 静 --
- 换手率 1.42%
- 52周最低 9.76
- 委 比 -1.15%
- 总股本 2974.83万
- 历史最高 31.29
- 量 比 0.60
- 振 幅 7.19%
- 历史最低 2.86
- 每 手 1
- 风险率 4.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearPoint Neuro CEO Joseph Burnett Reports Sale of Common Shares
ClearPoint Neuro CEO Joseph Burnett Reports Sale of Common Shares Joseph Burnett, CEO and President of ClearPoint Neuro Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (P
01-28 05:28
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software
ClearPoint Neuro receives EU certification for its navigation software, expanding brain surgery access as the company reports strong revenue growth and outlines higher sales expectations for 2026.
01-24 00:16
Booz Allen Posts Upbeat Q3 Earnings, Joins Life360, Redwire And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones falling around 200 points on Friday....
01-23 23:55
ClearPoint Neuro Receives EU MDR Certification for Navigation Software 3.0.2
ClearPoint Neuro Receives EU MDR Certification for Navigation Software 3.0.2 ClearPoint Neuro Inc. has announced that it has received EU MDR Certification for its ClearPoint Navigation Software Version 3.0.2. This regulatory approval allows the company to expand access to its latest operating room n
01-23 05:30
ClearPoint Neuro Reports Preliminary Q4 Revenue Of ~$10.4M, 2025 Revenue Of ~$37M
ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced preliminary unaudited revenue growth for
01-12 21:33
Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points o...
2025-12-16 23:53
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 38.7% to...
2025-12-16 20:05
ClearPoint Neuro Completes Acquisition of IRRAS Holdings
An announcement from ClearPoint Neuro ( ($CLPT) ) is now available. On November...
2025-11-21 06:25
ClearPoint Neuro Reports Q3 Results and Strategic Advances
ClearPoint Neuro ( ($CLPT) ) just unveiled an announcement. On November 6, 2025...
2025-11-07 06:52
ClearPoint Neuro Narrows FY2025 Sales Guidance from $36.000M-$41.000M to $36.000M-$38.000M vs $37.650M Est
ClearPoint Neuro (NASDAQ:CLPT) narrows FY2025 sales outlook from $36.000 million-$41.000 million to $36.000 million-$38.000 million vs $37.650 million estimate.
2025-11-07 06:02
